Aju Ib Investment Co., Ltd. Rallybio Corp Transaction History
Aju Ib Investment Co., Ltd.
- $58.4 Million
- Q3 2022
A detailed history of Aju Ib Investment Co., Ltd. transactions in Rallybio Corp stock. As of the latest transaction made, Aju Ib Investment Co., Ltd. holds 754,678 shares of RLYB stock, worth $716,944. This represents 18.69% of its overall portfolio holdings.
Number of Shares
754,678
Previous 754,678
-0.0%
Holding current value
$716,944
Previous $5.7 Million
91.65%
% of portfolio
18.69%
Previous 11.03%
Shares
1 transactions
Others Institutions Holding RLYB
# of Institutions
52Shares Held
31.9MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$3.99 Million0.02% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$3.45 Million1.36% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$3.45 Million1.69% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$3.14 Million3.98% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$2.88 Million0.08% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $30.5M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...